NCT06491446 2026-02-18
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Antiva Biosciences
Phase 1/2 Active not recruiting
Clinical Trials
14 trialsNCT07281599 2026-02-02
EQUIP
Qurasense
Phase NA Recruiting
NCT03984695 2026-01-28
SHE-WOMEN
University of Kansas Medical Center
Phase NA Active not recruiting
NCT02520986 2025-08-19
Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma
Zydolab - Institute of Cytology and Immune Cytochemistry
Phase NA Recruiting
NCT03981822 2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT05125380 2023-11-03
Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
Lund University
Phase NA Unknown
NCT02482428 2021-01-05
Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Novartis
Phase 2 Completed
NCT02572401 2019-10-15
STAND
University of Pennsylvania
Phase NA Completed
NCT02724254 2018-07-20
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Vaxart
Phase 2 Completed
NCT02535104 2018-06-06
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Tamir Biotechnology, Inc.
Phase 1/2 Completed
NCT01490359 2017-12-19
Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
University of Pennsylvania
Phase NA Completed
NCT00849823 2017-07-14
HIV Prevention Program for African American Teen Males
University of Kentucky
Phase NA Completed
NCT00314028 2013-12-16
Effectiveness of HIV Risk Reduction Program Among African American Men
University of Kentucky
Phase 3 Completed
NCT00124878 2007-08-10
Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
Wawer, Maria J., M.D.
Phase 3 Unknown